Treatment for melasma by metformin lotio
Phase 2
- Conditions
- Health Condition 1: L811- Chloasma
- Registration Number
- CTRI/2018/12/016588
- Lead Sponsor
- Hassan institute of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Patients having melasma of more than 18 years age.
2) Patients who are not on topical medications for melasma treatment for atleast 2 weeks , 1 month for systemic steroids, 3 months for laser, dermabrasion or
peels.
3) Patients who are willing to participate in the study.
Exclusion Criteria
1)Pregnant and lactating women
2) Patients on oral contraceptives, phenytoin
3) Patients with renal dysfunction.
4) Patients who are allergic to the investigating medications.
5) Patients with acne vulgaris, rosacea.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method